With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Defining the Molecular Mechanisms Underlying Pediatric Brain Tumor Penetrance||Washington University / Nicole Brossier, MD/PhD||Young Investigator Grants||2019||Missouri|
|Using Splice Switching Oligonucleotides (SSOs) to target MDM2 for rhabdomyosarcoma therapy||Research Institute at Nationwide Children's Hospital / Dawn Chandler, PhD||Innovation Grants||2019||Ohio|
|Investigation of Pediatric Rhabdomyosarcoma Recurrence through Single-Cell Sequencing||St. Jude Children's Research Hospital / Anand Patel, MD/PhD||Young Investigator Grants||2019||Tennessee|
|The Role of Tumor Heterogeneity in Relapse of Pediatric Acute Myeloid Leukemia||Children's Hospital & Research Center at Oakland / Cheryl Peretz, MD||Young Investigator Grants||2019||California|
|MLL Oncogene-Dependent Enhancer Reprogramming Promotes Leukemogenesis||Stanford University / Feng Pan, PhD||Young Investigator Grants||2019||California|
|Kidney Disease after CD19-Targeted Chimeric Antigen Receptor T Cell Therapy for Pediatric Acute Lymphoblastic Leukemia||Children's Hospital of Philadelphia / Regina Myers, MD||Young Investigator Grants||2019||Pennsylvania|
|Cooperating Signaling Networks Regulate Cell Survival of Pediatric Ph-like ALL||University of Pennsylvania / Christian Hurtz, PhD||Young Investigator Grants||2018||Pennsylvania|
|Alternative Splicing Driven by MYCN Activates RAS-MAPK in Neuroblastoma||University of California San Francisco / William Weiss, MD/PhD||Innovation Grants||2018||California|
|Accessing Combinatorial Effect of PARP Inhibitor with DNA Damaging Agent in Rhabdomyosarcoma at Single Cell Resolution||Massachusetts General Hospital / Chuan Yan, PhD||Young Investigator Grants||2018||Massachusetts|
|Targeting the ALT Pathway to Induce Synthetic Lethality and Treat Poor Outcome Pediatric Tumors||University of California, Davis / Wolf-Dietrich Heyer, PhD||Innovation Grants||2018||California|